ISSN: 2167-065X

Клиническая фармакология и биофармацевтика

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

Nanotechnology in Pharmaceutical Delivery System

Zhen Huang

Nanotechnology has revolutionized the field of drug delivery in the pharmaceutical industry. With the development of Nano scale particles and structures, drugs can now be targeted and delivered to specific sites within the body with greater precision and efficacy. One of the key advantages of nanotechnology in drug delivery is the ability to increase drug solubility, bioavailability, and stability. This is achieved by encapsulating drugs in Nano scale particles, which can protect them from degradation and enhance their absorption in the body. Additionally, nanoscale drug delivery systems can be designed to release drugs in a controlled manner, ensuring sustained therapeutic effects and minimizing potential side effects. Furthermore, nanotechnology-based delivery systems can be engineered to selectively target diseased cells or tissues, thereby reducing off-target effects and improving treatment outcomes. Overall, the use of nanotechnology in pharmaceutical delivery systems holds great promise for improving the effectiveness and safety of drug therapies. As such, it is an area of active research and development in the pharmaceutical industry.